Advertisement

1 of 7

Prev Next

Our Areas of Focus

Public Policy

Is the Polio Vaccine an Anti-Patent Success Story?
By Hans Sauer, Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Question from a Reader...

Read More >
Business and Investments

BIO CEO Company Snapshot: ImmunoGen, Inc.
In the latest Company Snapshot for the 2012 BIO CEO & Investor Conference in New York City, we're profiling ImmunoGen, Inc. wh...

Read More >
Corporate

2011: A Pivotal Year for Biotechnology
Biotechnology continues to hold the greatest promise to address many of the most critical issues facing our world. Continued inno...

Read More >
Environmental & Industrial

ARPA-E Helps Early Stage Companies Commercialize Energy Innovations
Q&A with ARPA-E Deputy Director for Commercialization Cheryl Martin Q: What is the mission of ARPA-E, and how do you work t...

Read More >
Events

2011 BIO International Convention Governors Highlight Reel
The 2011 BIO International Convention brought together over 15,000 leaders from industry, government and academia who are working...

Read More >
Food And Agriculture

Bill Gates: Embrace Genetic Modification or Starve
Bill Gates has a terse response to criticism that the high-tech solutions he advocates for world hunger are too expensive or bad f...

Read More >
Health

Let's Get PDUFA V Approved, Fast
By Marc Boutin, JD, Executive Vice President and Chief Operating Officer, National Health Council At this time of the year, it...

Read More >

Contact

You can leave a message using the contact form below.

Comments are closed.

Advertisement